Gallant was pitched on Shark Tank season 11 episode 8. It is a regenerative medicine business.
This medicine is also known as stem cell therapy. This is a kind of immature cell that helps to make other blood cells.
Stem Cell Therapy or regenerative medicine is very famous in the 20th century and there are a lot of people who are taking stem celltherapy to make their life better.
Step cells help to repair the dysfunctional and injured tissue and it boosts the life of the cells. Gallant stem cell therapy performs the same work but only for pets.
Aaron Hirschhorn set up the Gallant company in 2018 and the company was able to raise $11 million in funding from different investors like Daniel Curran, Unpopular Ventures, Slow Ventures, and so on till August 2019.
Aaron came up on Shark Tank intending to get an investment of $550000 in exchange for a 2% stake at a $25 million valuation. Aaron claimed an excessive valuation for the business from Shark.
Aaron himself had a successful stem cell therapy treatment for chronic back pain. He was deeply inspired by the outstanding effect of stem cell therapy. So he raised $11 million from Silicon Valley business people to launch Gallant.
The process of how Gallant works starts with a dog being sterilized by a veterinarian and its reproductive organs being shipped in a special way offered by Gallant.
After that, the organs are shipped to FDA-approved labs where the stem cells are isolated from the animal and frozen in liquid nitrogen. These stem cells are stored in Gallant’s labs. They are then shipped whenever they are required for treatment.
Gallant provides pet owners the choice of collecting and storing the stem cells of their dogs for a certain amount of money. They generally have two primary service plans: a yearly subscription of $95 to collect and store the cells or a lifetime service for $595.
Moreover, for the harvesting of the cells, veterinarians charge nearly $300. Although Gallant pet stem cell company encountered tough competition from various companies like ForeverTarget150 and Amnio Chor, it is active in business and continuously selling its products.
The approximate Gallant dog stem cell net worth is $10 million.
A Short Overview Of Gallant
Gallant is a San Diego, California-based regenerative medicine business that is designed to do something better for pets. Regenerative medicine is one of the most effective ways to repair injured cells.
The company offers 3 different plans: monthly, annual and lifetime. All these plans provide all services and for the plans, you have to spend $45, $395, and $990.
The company provides stem cell banking services for pets. They gather and store stem cells from pets so that they can be used for potential therapies in the future.
The stem cells help to enhance the quality of life for pets having osteoarthritis, skin conditions, and chronic dry eye conditions.
Gallant wants to offer pet owners a way to access the healing power of their pets’ younger stem cells if required. They provide a service where they gather and store stem cells from pets for potential use in future therapies.
Step cells are outstanding natural healers that are capable enough to treat different conditions and injuries.
When the pets grow older they face the effects of ageing like joint pain, limited mobility, and irritated skin. Conventional ways of treatment can be very costly and may have dangerous side effects.
Stem cell therapy provides an alternative way to address these problems. Gallant’s stem cell banking service enables pet owners to restore the stem cells of their pets at a younger and healthy age.
By storing these stem cells, pet owners can have a direct line to scientific improvement and potential outcomes if their pets need treatment in the future.
The testimonials from pet owners who have used Gallant’s services highlight the relief and peace of mind that stem cell banking brings. Restoring the stem cells is handled by Gallant and veterinary experts, making it easy for pet owners.
The concept of banking stem cells for pets with Gallant could decrease the cost of future treatments for pets and enhance their quality of life at the same time.
Aaron Hirschhorn is the person behind the foundation of Gallant Dog Company. He is also the CEO of the firm. He introduced the company in 2018. Before creating Gallant he set up a firm named DogVacay in 2012. River acquired the firm later in 2017.
Hirschhorn himself experienced stem cell therapy. He had undergone the treatment successfully for his chronic back pain.
When he found his dog suffering from chronic arthritis he understood that stem cell therapy may be useful for the animals. Getting motivated by this realization he approached his contacts in Silicon Valley and managed to raise a capital of $11 million to begin Gallant.
Before the foundation of Gallant, he founded DogVacay which is a famous pet-sitting service but he sold the company to Rover later.
Hirschhoron came up with the idea of Gallant because he believed that the usefulness of stem cell therapy, which is a new medical development, should not be limited to humans only. He saw that it is possible to bring this unique treatment for pets particularly those who suffer from age-related diseases like arthritis.
The concept is to accumulate and reserve the stem cells from pets during regular spaying or neutering methods, a procedure that was generally wasted, and use these cells later for regenerative therapies whenever the pet falls ill.
Before coming up on Shark Tank, Gallant had already made remarkable strides. They had successfully started partnerships with veterinary offices, which obtain the kits required to store pets’ stem cells and send them for storage.
The company also spent money on research and applied for four patents to save its unusual business idea. Despite these improvement elements, the company encountered various challenges, mainly in customer acquisition costs and the high cost of stem cell extraction. Gallant started to look for more funding due to these challenges.
Aaron Hirschhorn gave an outstanding pitch for Gallant on Shark Tank season 11. He came up on the Shark Tank stage with a basket of puppies.
Then he distributed a puppy to each shark and claimed that four out of the five puppies would likely suffer from age-related diseases in ten years. To describe his point he called in the Grim Reaper to gather all but one of the pups.
Hirschhorn appealed for an investment of $500,000 in exchange for a 2% equity in Gallant. He gave a rapid-fire description of how Gallant’s stem cell banking service could benefit pets from all over the world sharing his experience of reducing his back pain with stem cell therapies.
He had also added that he had made partnerships with veterinary offices, which obtain kits to bank pets’ stem cells and send them for storage, and his strategies to delve into stem-cell medicine.
Although Hirschhorn gave an outstanding presentation, the sharks were suspicious initially. They were worried about the financial stability of the business as Gallant was losing money on customer acquisition partially because they paid vets nearly $100 to take part in the stem cell banking procedure.
Moreover, the extraction procedure was very much expensive which led the company to burn a lot of money. For this reason, they raised $10 million for initial research.
Sharks Mark Cuban and guest Shark Anne Wojcicki were concerned about the proposition. On the other hand, Kevin O’Leary asked for financial numbers.
After listening to the pitch of Hirschhorn, O’Leary gave two proposals: $500,000 for 2% equity and 2% stock options, or $500,000 for 1% equity and a 10% royalty per kit in perpetuity.
Mark Cuban refused to invest in the business saying that he did not think the company had yet figured out its business model.
Nevertheless, Shark Lori Greiner found that Gallant had the potential to invest. Therefore she teamed up with Anne Wojcicki; they proposed to invest $500,000 in exchange for an 8% stake in the business.
Hirschhorn tried to negotiate with a counteroffer of 4% but Greiner and Wojcicki made a counteroffer of $500,000 in exchange for a 5% stake in the business.
Finally, Hirschhorn accepted the proposal and secured an investment from Lori Greiner and Anne Wojcicki.
Also Read: What Happened To FlunkkOFF After Shark Tank
Yes, Gallant was able to secure a deal on Shark Tank. Aaron Hirschhorn, the founder of the company, represented its stem cell banking service for pets on Shark Tank season 11.
He delivered a stunning pitch and shared his personal story and a demonstration with puppies. He was intending to get an investment of $500,000 for a 2% stake in the business.
The sharks were suspicious initially. Some of the sharks were concerned about the company’s pricing model and profitability. Kevin O’Leary made two proposals; nonetheless, Aaron didn’t accept either of them.
Mark Cuban also made up his mind not to invest, saying his belief that the company hadn’t quite figured everything out yet.
Ultimately, Lori Greiner and guest shark Anne Wojcicki found potential in the business and were determined to collaborate on an offer. They proposed $500,000 for 8% equity in Gallant.
Aaron made a counteroffer with 4%, which they then countered again with 5%. In the end, Aaron accepted their proposal of $500,000 for 5% equity.
Unfortunately, Hirschhorn breathed his last in 2021 in a tragic boating accident. Nevertheless, his company, Gallant, is still active and has seen success since its appearance on Shark Tank.
As per the reports, the annual revenue of the company is nearly $5.9 million. The partnership with Lori and Anne has been very useful for the business which enabled Aaron’s dream to continue despite his untimely death.
After appearing on Shark Tank, the company encountered a remarkable growth in its visibility and popularity which positively affected its business operations. Gallant managed to increase its annual revenue to $2.5 million.
Furthermore, the company was able to decrease the costs associated with banking pets’ stem cells, although they retained their $95 annual fee. This cost reduction could improve its affordability and appeal to a wider customer base.
Nevertheless, every development was not positive. The investment deal made on the show had not closed yet. In fact, despite Shark Anne Wojcicki’s recommendation to decrease the price, founder Aaron Hirschhorn lifted the price of the Gallant service from $595 to $890.
The company also launched a one-time setup plan costing $205. This implies that the company was still attempting to discover the optimal pricing technique to appeal to consumers while covering its costs.
Founder Aaron Hirschhorn had a tragic death in a boating accident in 2021 which denoted a remarkable change in Gallant’s business after their Shark Tank appearance. This was a remarkable clash of business.
Nevertheless, despite this unfortunate accident, the company is still committed to keeping Hirschhorn’s concept alive. The company is still functional and it is still producing its services.
As per the reports, Gallant is still in business selling its products actively and generating $5 million in sales per year.
Gallant is committed to improving pet health through unique stem cell treatments.
Is Gallant Still In Business?
As per the research, Gallan is still active in business as of 2023. But unfortunately, the founder of Gallant, Aaron Hirschhorn, passed away in 2021 due to a boating accident.
Despite his death, partnering with Lori Greiner and Anne Wojcicki has enabled his dream to continue.
Gallant has also boosted its annual revenue to about $5.9 million and has a great board of people and veterinarians supporting its success.
The current headquarters of this company is in San Diego, California, United States, and 11-50 employees are working in it.
So, Gallant Pet is still in business as of 2023.
The sharks liked the vision behind Gallant. Most importantly the pet owners loved it the most. Gallant not only helps to facilitate improving your canine friend’s quality of life but also it is a hassle-free process for the pet parent. Gallant is now a multi-million-dollar business that is encouraging stem cell research for canines. And it proceeds to make history – keeping Aaron’s legacy alive.
Also Read: What Happened To Liberate After Shark Tank
What is the net worth of Gallant Pet?
The current net worth of Gallant Pet is $45 million. The company was introduced in 2018 and it is still active in business as of 2023.
In 2020, this company was able to raise funding from 2Future and Alumni Ventures in the venture round.
The valuation of Gallant was $10 million after getting an investment from Lori Greiner and Anne Wojcicki on Shark Tank.
Why is Gallant so popular?
Gallant was designed to offer dogs regenerative care the same way it is offered to humans.
Gallant stores dumped reproductive organs in an FDA-approved lab. Then if a person’s dogs face medical or health issues where the stem cells have the chance of being a solution to their medical issue, they are given stem cell therapy.
Who is the founder of Gallant Pet?
Aaron Hirschhorn is the founder of Gallant Pet. As of 2023, the company is still active in business although Aaron, the founder of the company is no more.